Grant Detail
The grant detail shows the name of the PI, active dates of the project, the funding institute and the abstract of the grant. This abstract is what is used to create the fingerprint of the grant. If any publications referencing this grant are found in the data, they will be listed here as well.
ALZHEIMER NEUROFIBRILLARY DEGENERATION
1 August 1995 - 31 January 2003
FOGARTY INTERNATIONAL CENTER
Total Funding: $ 156,000
The objective of this Fogarty International Research Collaboration Award (FIRCA) proposal is to elucidate the mechanism of neurofibrillary degeneration in Alzheimer's disease (AD) by (I) studying the association of the AD abnormally hyperphosphorylated tau (AD P-tau) to various normal human tau isoforms, and (2) identifying the protein kinase(s) the phosphorylation of normal tau by which converts it to an AD-like state in sequestering normal microtubule associated proteins (MAP), MAP1 and MAP2 and depolymerizing microtubles. For Aim #1, each of the six recombinant human tau isoforms will be purified by column chromatography. The AD P-tau will be isolated from unfixed AD autopsied brains obtained within six hours postmortem and stored at -75 degrees C. The association between the AD P-tau and various recombinant tau isoforms will be assayed both by dot overlay and by the sedimentation assays, followed by quantitation of normal and AD P-tau with a radioimmuno-dot-blot assay using phosphorylation-dependent tau antibody, Tau-1, as the primary antibody. For Aim #2, we will isolate protein kinase C and CaM kinase-II from rat brain, glycogen synthase kinase-3, cyclin-dependent kinase-5 and casein kinase-I from bovine brain. The tau isoform found to associate the most to the AD P-tau will be in vitro phosphorylated by the above kinases and as well as protein kinase-A (PKA) and mitogen activated kinase (MAP kinase) obtained commercially, and the association of this in vitro phosphorylated tau with MAP1 and MAP2, and as a control with tau, will be examined as in Aim #1. Furthermore, the ability of the phosphorylated tau to depolymerize microtubules assembled by MAP1 and MAP2 will be investigated. The microtubule assembly and disassembly studies will be carried out by light scattering/turbidimeteric changes at 350 mm in microcuvettes, and by negative stain electron microscopy. These studies will help identify the role of different tau isoforms, the abnormai hyperphosphorylation of which convert them to a toxic molecule that can depolymerize the microtubule network, and identify the protein kinase(s) the phosphorylation of tau by which convert it into AD-like state and lead to neurofibrillary degeneration. This information will not only elucidate the mechanism of Alzheimer neurofibrillary degeneration but also provide a lead towards developing a rational therapeutical approach to the disease.
5 Resulting Publications
-
1.
2004Alejandra del C Alonso; Anna Mederlyova; Michal Novak; Inge Grundke-Iqbal; Khalid Iqbal
Promotion of hyperphosphorylation by frontotemporal dementia tau mutations.
The Journal of biological chemistry 2004;279(33):34873-81. -
2.
2001A D Alonso; T Zaidi; M Novak; H S Barra; I Grundke-Iqbal; K Iqbal
The Journal of biological chemistry 2001;276(41):37967-73. -
3.
2001A Alonso ; T Zaidi; M Novak; I Grundke-Iqbal; K Iqbal
Proceedings of the National Academy of Sciences of the United States of America 2001;98(12):6923-8. -
4.
1997A D Alonso; I Grundke-Iqbal; H S Barra; K Iqbal
Proceedings of the National Academy of Sciences of the United States of America 1997;94(1):298-303. -
5.
1996A C Alonso; I Grundke-Iqbal; K Iqbal
Nature medicine 1996;2(7):783-7.
Scientific Context
This section shows information that has been computed by using the fingerprint of the grant, including related publications, related experts and related grants - all with fingerprints representing significant amounts of overlap between their fingerprint and this grant. The red dots indicate whether those experts or terms actually appear within this grant, showing potential and actual connections.
Related Grants
-
1.
IQBAL, KHALID
NEURONAL CYTOSKELETAL ALTERATIONS IN ALZHEIMERS DISEASE
1 February 1991 - 31 January 2002
NATIONAL INSTITUTE ON AGING
Total Funding: $ 1,837,145
-
2.
THAL, LEON J
ALTERED PROTEIN KINASES IN ALZHEIMERS DISEASE
1 August 1988 - 31 July 1998
NATIONAL INSTITUTE ON AGING
Total Funding: $ 186,700
-
3.
IQBAL, KHALID
2 September 2011 - 30 June 2014
FOGARTY INTERNATIONAL CENTER
Total Funding: $ 70,352
Related Publications
-
1.
2002Jianzhi Wang; Xiaochuan Wang; Rong Liu; Qun Wang; Inge Grundke-Iqbal; Khalid Iqbal
In vitro analysis of tau phosphorylation sites and its biological activity.
Chinese medical sciences journal = Chung-kuo i hsüeh k'o hsüeh tsa chih / Chinese Academy of Medical Sciences 2002;17(1):13-6. -
2.
1997A Sengupta; Q Wu; I Grundke-Iqbal; K Iqbal; T J Singh
Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5.
Molecular and cellular biochemistry 1997;167(1-2):99-105. -
3.
1998J Z Wang; Q Wu; A Smith; I Grundke-Iqbal; K Iqbal
FEBS letters 1998;436(1):28-34.
Related Topics
Appears in this Publication
-
-
Microtubule Associated Prote...
-
-
-
-
-
-
-
-
-
-
-
Calcium-Calmodulin-Dependent...
-
Cyclic AMP-Dependent Protein...
-
-
-
-
-
-
Protein-Serine-Threonine Kin...
Related Experts
Author of this Publication
-
Internal ExpertsPublications
-
290









-
246









-
432









-
285









-
167









-
849










